156 MONDAY • MAY 16 P152 Facilitator: P153 P154 P155 P156 P157 P158 P159 Facilitator: P160 P161 P162 P163 Ghrelin Treatment Decreases Lung Inflammation and Fibrogenesis by Inducing M2 Macrophage Polarization/N.N. Rocha, M.D.O. Vasconcellos, C.B. Lisboa, G. Guimaraes, G.D.A. Padilha, L.A. Maia, J.D. Silva, C.M. Takiya, V. Capelozzi, P.L. Silva, P.R.M. Rocco, Rio de Janeiro, Brazil, p.A3152 A.M. Manicone, MD, Seattle, WA BRD9 Is a Novel Epigenetic Regulator for Human Alveolar Macrophages Polarization/Y. Morias, A. Schinwald, T. Naessens, H. Boyd, D. Cunoosamy, Molndal, Sweden, p.A3153 Induction of IL-17Rb and IL-25 in Human Monocytes and Macrophages Through the Action of Th2 Cytokine IL-4/N. Weathington, S.M. Kanth, J.S. Bednash, Q. Gong, R. Mallampalli, Pittsburgh, PA, p.A3154 The Effect of Tiotropium Bromide in Development of M2 Macrophages in Murine Model of Asthma/M. Jinno, S. Ohta, A. Tanaka, A. Fujiwara, Y. Uchida, R. Manabe, H. Furukawa, N. Kuwahara, Y. Fukuda, T. Kimura, K. Hirai, Y. Miyata, T. Homma, M. Yamamoto, Y. Watanabe, T. Yokoe, H. Sagara, Tokyo, Japan, p.A3155 Decellularized Wild Type and a-Galactosyltransferase Knockout Pig Lungs Stimulate M2 Phenotype in Human Monocyte/Macrophages/S. Wrenn, A. Coffey, F.E. Uhl, J. Bianchi, B. Dacken, T. Petersen, D.E. Wagner, J.E. Boyson, D.J. Weiss, Burlington, VT, p.A3156 Distinct Profiles of M2 Macrophage Markers Among Idiopathic Interstitial Pneumonias/M. Yamashita, R. Saito, M. Ogasawara, Y. Fukuda, H. Sasano, T. Sugai, K. Yamauchi, Morioka, Japan, p.A3157 SP-R210 (Myo18A) Isoforms as Intrinsic Modulators of Macrophage Priming and Activation/Z.C. Chroneos, L. Yang, M. Carrillo, Y. Wu, S. Diangelo, P. Silveyra, T.M. Umstead, E.S. Halstead, M. Davies, S. Hu, J. Floros, F.X. McCormack, N.D. Christensen, Hershey, PA, p.A3158 Critical Role of the Class A Scavenger Receptor on Alveolar Macrophages in Chronic Obstructive Pulmonary Disease Airway Inflammation/R. Dong, L. Xie, M. Zhou, Shanghai, China, p.A3159 S. Sengupta, MD, MPH, Philadelphia, PA Ethanol-Induced Oxidative Stress and Altered AMPK Signaling in Human Alveolar Macrophages/L. Kaphalia, B.S. Kaphalia, W.J. Calhoun, Galveston, TX, p.A3160 S-nitrosoglutathione Reductase (GSNOR) Deficiency Impairs Macrophage Phenotypic Differentiation/C. Guo, J. Gow, M. Govendraj, A.J. Gow, Piscataway, NJ, p.A3161 Ursolic Acid Inhibits Cigarette Smoke-Induced Alveolar Macrophages Activity Injury Via ERK Signaling Pathway/Y. Yin, G. Hou, Q. Wang, E. Li, J. Kang, Shen Yang City, China, p.A3162 Increased Number of Macrophages in the Induced Sputum for Patients with Acute Myocardial Infarction/N. Kononova, G. Einvik, A. Hoiseth, A. Neukamm, T. Omland, V. Søyseth, Oslo, Norway, p.A3163 P164 P165 B33 Alveolar Macrophage-Mediated Efferocytosis in Alpha-1 Antitrypsin Deficiency/U. Parthasarathy, K. Krotova, M. Brantly, Gainesville, FL, p.A3164 miR-451 Regulates Allergic Lung Inflammation Via Sirt2-Mediated Alternative Macrophage Activation/Y.G. Lee, S. Chung, M. Karpurapu, M.N. Ballinger, B.F. Reader, J. Deng, Q. Feng, J. Christman, Columbus, OH, p.A3165 THEMATIC POSTER SESSION ANTIOXIDANTS, VITAMINS AND RELATED PATHWAYS IN AIRWAYS DISEASE 9:00 a.m. - 4:15 p.m. MOSCONE CENTER Viewing: Posters will be on display for entire session. Area B, Hall D (North Building, Lower Level) Discussion: 11:00-11:45: authors will be present for individual discussion 11:45-12:45: authors will be present for discussion with assigned facilitators Facilitator: P169 P170 P171 P172 P173 P174 J.S. Deshane, PhD, Birmingham, AL Vitamin E Isoform g-Tocotrienol Attenuates Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease/ H.Y. Peh, W.D. Tan, T.K. Chan, C.N. Ong, W.F. Wong, Singapore, Singapore, p.A3166 Impact of Vitamin D3 Deficiency on Airway Vitamin D Metabolism and Inflammation in a Murine Model of Atopic Chronic Rhinosinusitis/J.K. Mulligan, R. Schlosser, W. Pasquini, B.P. O’Connell, C. Atkinson, Charleston, SC, p.A3167 Cord Blood Vitamin D Levels and Gene Expression Profiles at Birth Are Associated with Wheezing in the First Year of Life: Results from the Vitamin D Antenatal Asthma Reduction Trial (VDAART)/A. Al Garawi, V.J. Carey, W. Qiu, H. Mirzakhani, A.A. Litonjua, S.T. Weiss, Boston, MA, p.A3168 Vitamin D Supplementation in Pregnant Women of Different Races and the Risk of Asthma/Recurrent Wheeze in the Child: Findings from the Vitamin D Antenatal Asthma Reduction Trial (VDAART)/H.M. Wolsk, B.J. Harshfield, N. Laranjo, V.J. Carey, G.T. O’Connor, M. Sandel, R.C. Strunk, L.B. Bacharier, R.S. Zeiger, M. Schatz, B.W. Hollis, S.T. Weiss, A.A. Litonjua, Boston, MA, p.A3169 Effect of Vitamin D on Cytokines Gene Expression and Corticosteroid Receptors of Asthmatic Patients in the United Arab Emirates/B. Mahboub, A. Alzaabi, R.M. Seliem, L.I. Salameh, S.M. Toor, F.S. Shendi, O.M. Al Ali, B.K. Saffarini, W.T. Erabia, A. Mogas, S. Audusseau, V. Narayanan, Q. Hamid, Sharjah, United Arab Emirates, p.A3170 Age and Gender-Specific Protective Effects of Superoxide Dismutase in Asthma Severity/S.A.A. Comhair, S.M. Baicker-McKee, E. Bleeker, M. Castro, J.V. Fahy, E. Israel, N. Jarour, B.D. Levy, D. Mauger, S.E. Wenzel, W.G. Teague, B. Gaston, S.C. Erzurum, Cleveland, OH, p.A3171 ATS 2016 • San Francisco
MONDAY • MAY 16 157 Facilitator: P175 P176 P177 P178 P179 P180 P181 B34 C. Taube, MD, Leiden, Netherlands Superoxide Dismutase Activity, Oxidative DNA Damage, and Nitric Oxide in Ethiopian High Altitude Populations/A.J. Janocha, A. Gebremedhin, A. Khan, K.S. Ricci, L. Monocello, R. Zhang, S.A.A. Comhair, S.C. Erzurum, C.M. Beall, Cleveland, OH, p.A3172 Airway Adaptation in a Murine Model of Irritant-Induced Asthma Is Dependent on the Foxp3 Pathway but Not on Regulatory T Cells/B. Allard, S. Farahnak, A. Panariti, J. Downey, T. McGovern, S. Ano, G. Kaufman, B. Mazer, W. Powell, M. Divangahi, J.G. Martin, Montreal, Canada, p.A3173 Effects of Aqueous and Hydroethanolic Pyrostegia Venusta Extracts in an Experimental Model of Allergic Asthma/A.C. Balestra, C. Sandy, A.M.S. Pereira, F. Carmona, M.C. Borges, Ribeirao Preto, Brazil, p.A3174 The Process of Development of Lung Fibrosis in the Rheumatoid Arthritis Lung Model and the Effect of H2 Treatment in D1CC Mice/Y. Terasaki, N. Kokuho, M. Terasaki, S. Kunugi, H. Urushiyama, M. Maruyama, T. Akimoto, S. Kanazawa, Tokyo, Japan, p.A3175 Nrf2 Mediates the Antioxidant Response to Organic Dust-Induced Oxidative Stress In Vivo and In Vitro/T. McGovern, M. Chen, S. Farahnak, M. O’Sullivan, S. Ano, B. Allard, K. Larsson, J.G. Martin, M. Adner, Montreal, Canada, p.A3176 The Antioxidant Transcription Factor Nrf2 Is an Important Regulator of Th17 Development/T.J. Chapman, S. Hillman, S. Knowlden, S. Georas, Rochester, NY, p.A3177 Rapid Vs Slow Supplementation of Vitamin D-Deficient Asthmatic Children: A Randomized Study/B.L. Davidson, K. Alansari, K.I. Yousef, I. Alattar, Burien, WA, p.A7810 THEMATIC POSTER SESSION CASE REPORTS IN IMMUNODEFICIENCES AND ALLERGY 9:00 a.m. - 4:15 p.m. MOSCONE CENTER Viewing: Posters will be on display for entire session. Area B, Hall D (North Building, Lower Level) Discussion: 11:00-11:45: authors will be present for individual discussion 11:45-12:45: authors will be present for discussion with assigned facilitators Facilitator: N.A. Parada, MD, New Orleans, LA P184 Interstitial Lung Disease Associated with HIV/J. Lee, N. Ali, H. Nazir, H. Seethamraju, Newark, NJ, p.A3178 P185 P186 A Japanese Patient Diagnosed Good Syndrome with Prolonged Time After Thymectomy/T. Nishizawa, D. Kurai, T. Saraya, H. Ishii, H. Takizawa, Mitaka Tokyo, Japan, p.A3179 Ground Glass Nodules and Cough in an Individual with Common Variable Immunodeficiency/P. Vishwasrao, K. Yaddanapudi, J. Davis, T. Gabig, A. Desai, Stony Brook, NY, p.A3180 P187 P188 P189 P190 Not Every Wheezing Is Asthma: A Case of Hypersensitivity Pneumonitis/H. Bhartee, A.V. Chandran, J. Devasahayam, Y. Oba, Columbia, MO, p.A3181 Intravenous Immunoglobulin as a Steroid-Sparing Agent to Treat Refractory Bronchiolitis Obliterans in a Patient Without Sinopulmonary Infections/C. Halpin, E. McGovern, J. Hoag, Philadelphia, PA, p.A3182 To Steroid, or Not to Steroid: A Case Study Reviewing Controversial Corticosteroid Treatment in Levamisole-Induced Leukocytoclastic Vasculitis/K. Gupta, P. Aleksiejuk, A. Kalakonda, P. Kohlitz, Syracuse, NY, p.A3183 Anaphylaxis to Vancomycin in Setting of IL-2 Induced Eosinophilia/D. Mann, M. Wong, B. Schneider, B. Modena, R. Sell, La Jolla, CA, p.A3184 P191 Two Tumours, Neuropathy, Infections/K. Bhaskar, G. Paramjyothi, A.K. Meena, N. Narendra Kumar, N. Ismail, B. Rajendra Prasad, S. Laxma Reddy, K. Vara Prasad, Hyderabad, India, p.A3185 Facilitator: P192 P193 P194 P195 R. Sehmi, PhD, Hamilton, Canada Primary Effusion Lymphoma and Initiation of HAART in a Critically Ill Patient with AIDS/A. McCambridge, C. Zhang, J. O’Horo, P. Escalante, Rochester, MN, p.A3186 Rare Presentation of Selective Immunoglobin M Deficiency in Patient with Recurrent Pneumonia/R. Hsiao, M. McCarra, T. Sharma, San Diego, CA, p.A3187 E Cigarettes - ‘Harmless Vapor’ or ‘Life Threatening Inhaled Toxin? A Case of Potential Laryngeal Edema Due to Electronic Cigarette Vapor Exposure Necessitating Intubation in a Young Woman/Y. Naidu, A. Croake, N. Mehta, M. Jawish, D. Lingutla, Rochester, NY, p.A3188 Allergic Bronchopulmonary Aspergillosis Treated with Omalizumab/A. Reyes Esteves, L.A. Soto, H. Bhatti, Orlando, FL, p.A3189 P196 A Unique Presentation of DRESS/M. Yaqoob, A. Alkhatib, C. Nader, Brighton, MA, p.A3190 P197 P198 A Case of Life Threatening Acute Isolated Uvular Edema/S.M. Eikermann, G. Shanmuganatha, R.R. Holmes, C. Bulathsinghala, Corpus Christi, TX, p.A3191 The Interaction of Pulmonary and Extrapulmonary Complications of Common Variable Immunodeficiency Resulting in Severe Respiratory Failure/A. Damodaran, D.E. Schraufnagel, Chicago, IL, p.A3192 P199 A Rare Case of Angioedema/R. Chugh, L. Gross, K. Keshava, A. Mahjoub, A.Y. Huang, Brooklyn, NY, p.A3193 MONDAY MORNING ATS 2016 • San Francisco
- Page 1 and 2:
American Thoracic Society Internati
- Page 3:
TABLE OF CONTENTS ATS 2016 INTERNAT
- Page 6 and 7:
2 FRIDAY • MAY 13 PG2A CLINICAL P
- Page 8 and 9:
4 FRIDAY • MAY 13 Target Audience
- Page 10 and 11:
6 FRIDAY • MAY 13 11:15 Case Disc
- Page 12 and 13:
8 FRIDAY • MAY 13 Chairing: H.B.
- Page 14 and 15:
10 FRIDAY • MAY 13 10:25 Advanced
- Page 16 and 17:
12 FRIDAY • MAY 13 Objectives At
- Page 18 and 19:
14 SATURDAY • MAY 14 Abdominal Ul
- Page 20 and 21:
16 SATURDAY • MAY 14 PG17 BASIC
- Page 22 and 23:
18 SATURDAY • MAY 14 1:05 In What
- Page 24 and 25:
20 SATURDAY • MAY 14 10:30 Practi
- Page 26 and 27:
22 SATURDAY • MAY 14 Objectives A
- Page 28 and 29:
24 SATURDAY • MAY 14 10:10 Is My
- Page 30 and 31:
26 SUNDAY • MAY 15 Chairing: D.M.
- Page 32 and 33:
28 SUNDAY • MAY 15 Chronic Cough:
- Page 34 and 35:
30 SUNDAY • MAY 15 • understand
- Page 36 and 37:
32 SUNDAY • MAY 15 Target Audienc
- Page 38 and 39:
34 SUNDAY • MAY 15 Oral Presentat
- Page 40 and 41:
36 SUNDAY • MAY 15 9:15 Hyperpola
- Page 42 and 43:
38 SUNDAY • MAY 15 310 A Smartpho
- Page 44 and 45:
40 SUNDAY • MAY 15 103 Immunosupp
- Page 46 and 47:
42 SUNDAY • MAY 15 A26 POSTER DIS
- Page 48 and 49:
44 SUNDAY • MAY 15 822 Incidence
- Page 50 and 51:
46 SUNDAY • MAY 15 519 Maternal H
- Page 52 and 53:
48 SUNDAY • MAY 15 P14 P15 P16 P1
- Page 54 and 55:
50 SUNDAY • MAY 15 P1545 P1546 Fa
- Page 56 and 57:
52 SUNDAY • MAY 15 P60 P61 Facili
- Page 58 and 59:
54 SUNDAY • MAY 15 P149 P150 Faci
- Page 60 and 61:
56 SUNDAY • MAY 15 P749 P750 P751
- Page 62 and 63:
58 SUNDAY • MAY 15 Facilitator: P
- Page 64 and 65:
60 SUNDAY • MAY 15 P1243 P1244 P1
- Page 66 and 67:
62 SUNDAY • MAY 15 P1295 P1296 P1
- Page 68 and 69:
64 SUNDAY • MAY 15 P1358 P1359 P1
- Page 70 and 71:
66 SUNDAY • MAY 15 P91 Facilitato
- Page 72 and 73:
68 SUNDAY • MAY 15 P616 P617 P618
- Page 74 and 75:
70 SUNDAY • MAY 15 P914 P915 P916
- Page 76 and 77:
72 SUNDAY • MAY 15 P556 P557 P558
- Page 78 and 79:
74 SUNDAY • MAY 15 Facilitators:
- Page 80 and 81:
76 SUNDAY • MAY 15 P997 P998 P999
- Page 82 and 83:
78 SUNDAY • MAY 15 P256 P257 P258
- Page 84 and 85:
80 SUNDAY • MAY 15 A61 THEMATIC P
- Page 86 and 87:
82 SUNDAY • MAY 15 P824 Facilitat
- Page 88 and 89:
84 SUNDAY • MAY 15 P1055 P1056 P1
- Page 90 and 91:
86 SUNDAY • MAY 15 P1101 P1102 P1
- Page 92 and 93:
88 SUNDAY • MAY 15 P1423 P1424 P1
- Page 94 and 95:
90 SUNDAY • MAY 15 P1474 P1475 P1
- Page 96 and 97:
92 SUNDAY • MAY 15 P377 P378 P379
- Page 98 and 99:
94 SUNDAY • MAY 15 P281 P282 P283
- Page 100 and 101:
96 SUNDAY • MAY 15 P450 P451 A74
- Page 102 and 103:
98 SUNDAY • MAY 15 P1562 P1563 P1
- Page 104 and 105:
100 SUNDAY • MAY 15 A80-A THEMATI
- Page 106 and 107:
102 SUNDAY • MAY 15 Facilitator:
- Page 108 and 109:
104 SUNDAY • MAY 15 11:00 a.m.-12
- Page 110 and 111: 106 SUNDAY • MAY 15 L1 U.S. FOOD
- Page 112 and 113: 108 SUNDAY • MAY 15 12:15 Post-Pr
- Page 114 and 115: 110 SUNDAY • MAY 15 MP406 MP407 M
- Page 116 and 117: 112 SUNDAY • MAY 15 clinician and
- Page 118 and 119: 114 SUNDAY • MAY 15 A86 BASIC •
- Page 120 and 121: 116 SUNDAY • MAY 15 Chairing: M.J
- Page 122 and 123: 118 SUNDAY • MAY 15 3:30 High Pre
- Page 124 and 125: 120 SUNDAY • MAY 15 102 Toll-Like
- Page 126 and 127: 122 SUNDAY • MAY 15 A103 POSTER D
- Page 128 and 129: 124 SUNDAY • MAY 15 719 Lactate R
- Page 130 and 131: 126 SUNDAY • MAY 15 1014 Determin
- Page 132 and 133: 128 SUNDAY • MAY 15 611 Plasma Mi
- Page 134 and 135: 130 SUNDAY • MAY 15 412 Daytime S
- Page 136 and 137: 132 SUNDAY • MAY 15 6:30 p.m. - 8
- Page 138 and 139: 134 MONDAY • MAY 16 SS111 SS112 S
- Page 140 and 141: 136 MONDAY • MAY 16 Target Audien
- Page 142 and 143: 138 MONDAY • MAY 16 9:40 Empoweri
- Page 144 and 145: 140 MONDAY • MAY 16 9:28 Endotoxi
- Page 146 and 147: 142 MONDAY • MAY 16 10:15 Adaptiv
- Page 148 and 149: 144 MONDAY • MAY 16 Oral Presenta
- Page 150 and 151: 146 MONDAY • MAY 16 624 Neonatal
- Page 152 and 153: 148 MONDAY • MAY 16 118 Compariso
- Page 154 and 155: 150 MONDAY • MAY 16 912 Should Pa
- Page 156 and 157: 152 MONDAY • MAY 16 1015 Resverat
- Page 158 and 159: 154 MONDAY • MAY 16 718 Health Re
- Page 162 and 163: 158 MONDAY • MAY 16 B35 THEMATIC
- Page 164 and 165: 160 MONDAY • MAY 16 P252 P253 P25
- Page 166 and 167: 162 MONDAY • MAY 16 P406 P407 P40
- Page 168 and 169: 164 MONDAY • MAY 16 P320 Bilatera
- Page 170 and 171: 166 MONDAY • MAY 16 B40 THEMATIC
- Page 172 and 173: 168 MONDAY • MAY 16 P528 P529 Fac
- Page 174 and 175: 170 MONDAY • MAY 16 Facilitator:
- Page 176 and 177: 172 MONDAY • MAY 16 B44 THEMATIC
- Page 178 and 179: 174 MONDAY • MAY 16 P484 P485 P48
- Page 180 and 181: 176 MONDAY • MAY 16 P1161 P1162 P
- Page 182 and 183: 178 MONDAY • MAY 16 B48 THEMATIC
- Page 184 and 185: 180 MONDAY • MAY 16 P1238 P1239 P
- Page 186 and 187: 182 MONDAY • MAY 16 P1297 P1298 P
- Page 188 and 189: 184 MONDAY • MAY 16 Facilitator:
- Page 190 and 191: 186 MONDAY • MAY 16 P15 P16 P17 P
- Page 192 and 193: 188 MONDAY • MAY 16 Facilitator:
- Page 194 and 195: 190 MONDAY • MAY 16 P114 P115 P11
- Page 196 and 197: 192 MONDAY • MAY 16 P1408 Enhance
- Page 198 and 199: 194 MONDAY • MAY 16 P1455 P1456 P
- Page 200 and 201: 196 MONDAY • MAY 16 P1487 P1488 P
- Page 202 and 203: 198 MONDAY • MAY 16 P1514 P1515 P
- Page 204 and 205: 200 MONDAY • MAY 16 Facilitator:
- Page 206 and 207: 202 MONDAY • MAY 16 P559 P560 P56
- Page 208 and 209: 204 MONDAY • MAY 16 WS3 CLINICAL
- Page 210 and 211:
206 MONDAY • MAY 16 Satellite ear
- Page 212 and 213:
208 MONDAY • MAY 16 Objectives At
- Page 214 and 215:
210 MONDAY • MAY 16 encourage tra
- Page 216 and 217:
212 MONDAY • MAY 16 B82 BEHAVIORA
- Page 218 and 219:
214 MONDAY • MAY 16 B86 BASIC •
- Page 220 and 221:
216 MONDAY • MAY 16 and a number
- Page 222 and 223:
218 MONDAY • MAY 16 2:30 Mortalit
- Page 224 and 225:
220 MONDAY • MAY 16 3:00 Simultan
- Page 226 and 227:
222 MONDAY • MAY 16 525 Clinical
- Page 228 and 229:
224 MONDAY • MAY 16 320 Sensitivi
- Page 230 and 231:
226 MONDAY • MAY 16 113 COPD Subt
- Page 232 and 233:
228 MONDAY • MAY 16 1004 Health C
- Page 234 and 235:
230 MONDAY • MAY 16 609 Skeletal
- Page 236 and 237:
232 MONDAY • MAY 16 5:00 p.m. - 7
- Page 238 and 239:
234 TUESDAY • MAY 17 Chairing: D.
- Page 240 and 241:
236 TUESDAY • MAY 17 CLINICAL YEA
- Page 242 and 243:
238 TUESDAY • MAY 17 This session
- Page 244 and 245:
240 TUESDAY • MAY 17 bronchiectas
- Page 246 and 247:
242 TUESDAY • MAY 17 Target Audie
- Page 248 and 249:
244 TUESDAY • MAY 17 C18 MINI SYM
- Page 250 and 251:
246 TUESDAY • MAY 17 415 Investig
- Page 252 and 253:
248 TUESDAY • MAY 17 207 Survival
- Page 254 and 255:
250 TUESDAY • MAY 17 906 Phenotyp
- Page 256 and 257:
252 TUESDAY • MAY 17 807 The Vali
- Page 258 and 259:
254 TUESDAY • MAY 17 515 Roles of
- Page 260 and 261:
256 TUESDAY • MAY 17 P383 P384 P3
- Page 262 and 263:
258 TUESDAY • MAY 17 Facilitator:
- Page 264 and 265:
260 TUESDAY • MAY 17 P199 P200 P2
- Page 266 and 267:
262 TUESDAY • MAY 17 P620 Facilit
- Page 268 and 269:
264 TUESDAY • MAY 17 P428 P429 P4
- Page 270 and 271:
266 TUESDAY • MAY 17 P442 P443 P4
- Page 272 and 273:
268 TUESDAY • MAY 17 P318 P319 P3
- Page 274 and 275:
270 TUESDAY • MAY 17 P474 P475 Fa
- Page 276 and 277:
272 TUESDAY • MAY 17 Facilitator:
- Page 278 and 279:
274 TUESDAY • MAY 17 P727 P728 P7
- Page 280 and 281:
276 TUESDAY • MAY 17 P774 P775 Fa
- Page 282 and 283:
278 TUESDAY • MAY 17 C53 THEMATIC
- Page 284 and 285:
280 TUESDAY • MAY 17 C55 THEMATIC
- Page 286 and 287:
282 TUESDAY • MAY 17 P1095 P1096
- Page 288 and 289:
284 TUESDAY • MAY 17 P1167 P1168
- Page 290 and 291:
286 TUESDAY • MAY 17 P632 P633 P6
- Page 292 and 293:
288 TUESDAY • MAY 17 P546 P547 P5
- Page 294 and 295:
290 TUESDAY • MAY 17 Facilitator:
- Page 296 and 297:
292 TUESDAY • MAY 17 C65 THEMATIC
- Page 298 and 299:
294 TUESDAY • MAY 17 P659 P660 P6
- Page 300 and 301:
296 TUESDAY • MAY 17 P1506 P1507
- Page 302 and 303:
298 TUESDAY • MAY 17 C70 THEMATIC
- Page 304 and 305:
300 TUESDAY • MAY 17 P1363 P1364
- Page 306 and 307:
302 TUESDAY • MAY 17 P928 P929 P9
- Page 308 and 309:
304 TUESDAY • MAY 17 P973 P974 Fa
- Page 310 and 311:
306 TUESDAY • MAY 17 Facilitator:
- Page 312 and 313:
308 TUESDAY • MAY 17 C80 THEMATIC
- Page 314 and 315:
310 TUESDAY • MAY 17 P98 P99 P100
- Page 316 and 317:
312 TUESDAY • MAY 17 • become a
- Page 318 and 319:
314 TUESDAY • MAY 17 The topics a
- Page 320 and 321:
316 TUESDAY • MAY 17 C85 BASIC
- Page 322 and 323:
318 TUESDAY • MAY 17 C89 BASIC
- Page 324 and 325:
320 TUESDAY • MAY 17 3:20 Pediatr
- Page 326 and 327:
322 TUESDAY • MAY 17 2:45 Long-Te
- Page 328 and 329:
324 TUESDAY • MAY 17 918 Sarcoido
- Page 330 and 331:
326 TUESDAY • MAY 17 410 Effectiv
- Page 332 and 333:
328 TUESDAY • MAY 17 710 Follista
- Page 334 and 335:
330 TUESDAY • MAY 17 509 A Mechan
- Page 336 and 337:
332 TUESDAY • MAY 17 806 Upper Ai
- Page 338 and 339:
334 WEDNESDAY • MAY 18 6:45 Acute
- Page 340 and 341:
336 WEDNESDAY • MAY 18 CLINICAL Y
- Page 342 and 343:
338 WEDNESDAY • MAY 18 Objectives
- Page 344 and 345:
340 WEDNESDAY • MAY 18 D9 BASIC
- Page 346 and 347:
342 WEDNESDAY • MAY 18 Oral Prese
- Page 348 and 349:
344 WEDNESDAY • MAY 18 10:15 Plas
- Page 350 and 351:
346 WEDNESDAY • MAY 18 419 A Nove
- Page 352 and 353:
348 WEDNESDAY • MAY 18 216 Simpli
- Page 354 and 355:
350 WEDNESDAY • MAY 18 815 Multip
- Page 356 and 357:
352 WEDNESDAY • MAY 18 D28 POSTER
- Page 358 and 359:
354 WEDNESDAY • MAY 18 720 Repeat
- Page 360 and 361:
356 WEDNESDAY • MAY 18 P389 Facil
- Page 362 and 363:
358 WEDNESDAY • MAY 18 P439 P440
- Page 364 and 365:
360 WEDNESDAY • MAY 18 P10 P11 P1
- Page 366 and 367:
362 WEDNESDAY • MAY 18 P52 P53 Fa
- Page 368 and 369:
364 WEDNESDAY • MAY 18 P95 P96 P9
- Page 370 and 371:
366 WEDNESDAY • MAY 18 P698 P699
- Page 372 and 373:
368 WEDNESDAY • MAY 18 D42 THEMAT
- Page 374 and 375:
370 WEDNESDAY • MAY 18 P748 Funge
- Page 376 and 377:
372 WEDNESDAY • MAY 18 P353 P354
- Page 378 and 379:
374 WEDNESDAY • MAY 18 P172 P173
- Page 380 and 381:
376 WEDNESDAY • MAY 18 P808 Facil
- Page 382 and 383:
378 WEDNESDAY • MAY 18 P526 P527
- Page 384 and 385:
380 WEDNESDAY • MAY 18 P579 P580
- Page 386 and 387:
382 WEDNESDAY • MAY 18 P944 P945
- Page 388 and 389:
384 WEDNESDAY • MAY 18 P991 P992
- Page 390 and 391:
386 WEDNESDAY • MAY 18 P1036 P103
- Page 392 and 393:
388 WEDNESDAY • MAY 18 P1062 P106
- Page 394 and 395:
390 WEDNESDAY • MAY 18 11:45 Intr
- Page 396 and 397:
392 WEDNESDAY • MAY 18 12:15 Upda
- Page 398 and 399:
394 WEDNESDAY • MAY 18 This sessi
- Page 400 and 401:
396 WEDNESDAY • MAY 18 1:30 The B
- Page 402 and 403:
398 WEDNESDAY • MAY 18 D88 BEHAVI
- Page 404 and 405:
400 WEDNESDAY • MAY 18 3:00 Accel
- Page 406 and 407:
402 WEDNESDAY • MAY 18 D96 MINI S
- Page 408 and 409:
404 WEDNESDAY • MAY 18 604 CARMA3
- Page 410 and 411:
406 WEDNESDAY • MAY 18 702 Potent
- Page 412 and 413:
408 WEDNESDAY • MAY 18 803 ICU Ac
- Page 414 and 415:
410 WEDNESDAY • MAY 18 Chairing:
- Page 416 and 417:
412 WEDNESDAY • MAY 18 404 Interm
- Page 418:
Where today’s science meets tomor